SUMMARY A female with Duchenne muscular dystrophy, diagnosed at the age of 3 years 8 months, is reported. Chromosome studies revealed an X;autosome reciprocal translocation t(X;5)(p21-2;q31-2). With the BrdU-Hoechst 33258-Giemsa technique, there was nonrandom preferential inactivation of the normal X. Our patient is the ninth reported case of Duchenne muscular dystrophy associated with an X;autosome translocation. In all cases the breakpoint in the X chromosome is in band p21 at or near the site of the DMD gene.
Duchenne muscular dystrophy (DMD) is a severe X linked recessive disorder. Over the past few years, nine females each with progressive muscular dystrophy and an X;autosome translocation have been reported. 1-13 In each case, the breakpoint on the X chromosome was in band Xp2l. This suggested that the gene responsible for Duchenne muscular dystrophy is situated in band Xp2l and that the translocation has disrupted the normal gene function on the X chromosome. This paper describes the clinical history and investigations in a female with Duchenne muscular dystrophy with an X;5 translocation (previously reported in abstract form'2).
Case report
The patient, a female, born at term after an uneventful pregnancy was the only child of a 20. year old mother and a 23 year old father. Birth weight was 2750 g. There was no family history of neurological or muscle disease. She was first evaluated at the age of 3 years 8 months because of delayed speech and DMD was diagnosed. She sat unaided at 9 months, stood at 11 months, and walked at 16 months. Since the age of 2 years 6 months, she '3 1984 t(X;9)(p21;p2l) ( examined, the late replicating X was the normal one, indicating a non-random preferential inactivation. The parents' chromosomes were normal.
Discussion
Our patient is the ninth reported female with Duchenne muscular dystrophy resulting from a structural alteration of the short arm of the X chromosome -3 (table) . Cytogenetic studies in the nine females showed an X;autosome translocation involving a break in band Xp21 and breaks in seven different autosomes (chromosomes 1, 3, 5 (two cases), 6, 9 (two cases), 11, and 21). In each case the translocation was de novo and the normal X was late replicating. In no instance was the mother a proven carrier for the DMD gene. In our case, there was a negative family history and no compelling data to suggest that the mother was heterozygous for the DMD gene. The findings provide strong evidence that the DMD locus is situated within the Xp21 band and that in each of the nine reported cases the mutation is the direct result of the translocation. The translocation presumably has disrupted the normal activity of the DMD gene which, together with the non-random inactivation of the normal X chromosome, results in the manifestation of Duchenne muscular dystrophy. 
